The original hypothesis was that CLX and IFX would protect against sepsis through their anti-inflammatory and antioxidant effects, which were speculated to involve the modulation of two pathways that are known to be upregulated during sepsis; the COX-2 and TNF-α pathways, respectively. The gene discussed is TNF; the disease is Sepsis.